Abstract: Transforming growth factor-b (TGF-b) is a major regulator of collagen gene expression in human skin fibroblasts. Cellular responses to TGF-b are mediated primarily through its cell surface type I (TbRI) and type II (TbRII) receptors. Ultraviolet (UV) irradiation impairs TGF-b signalling largely due to reduced TbRII gene expression, thereby decreasing type I procollagen synthesis, in human skin fibroblasts. UV irradiation does not alter either TbRII mRNA or protein stability, indicating that UV reduction in TbRII expression likely results from transcriptional or translational repression. To understand how UV irradiation regulates TbRII transcription, we used a series of TbRII promoter-luciferase 5 0 -deletion constructs (covering 2 kb of the TbRII proximal promoter) to determine transcriptional rate in response to UV irradiation. We identified a 137-bp region upstream of the transcriptional start site that exhibited high promoter activity and was repressed 60% by UV irradiation, whereas all other TbRII promoter reporter constructs exhibited either low promoter activities or no regulation by UV irradiation. Mutation of potential transcription factor binding sites within the promoter region revealed that an inverted CCAAT box (À81 bp from transcription start site) is required for promoter activity. Mutation of the CCAAT box completely abolished UV irradiation regulation of the TbRII promoter. Protein-binding assay, as determined by electrophoretic mobilityshift assays (EMSAs) using the inverted CCAAT box as probe (À100/À62), demonstrated significantly enhanced protein binding in response to UV irradiation. Super shift experiments indicated that nuclear factor Y (NFY) is able to binding to this sequence, but NFY binding was not altered in response to UV irradiation, indicating additional protein(s) are capable of binding this sequence in response to UV irradiation. Taken together, these data indicate that UV irradiation reduces TbRII expression, at least partially, through transcriptional repression. This repression is mediated by a 38-bp sequence in TbRII promoter, in human skin fibroblasts.
Introduction
The most abundant structural protein in human skin is type I procollagen, which is responsible for the skin's strength and resiliency. Dermal fibroblasts are primary cellular source for type I collagen synthesis. Alteration of skin collagen content and organization impair wound healing, contribute to skin cancer and are responsible for skin fragility in the elderly (1) (2) (3) (4) .
Transforming growth factor-b (TGF-b) is a major regulator of collagen gene expression in human skin fibroblasts. Cellular responses to TGF-b are mediated primarily through its cell surface type I receptor (TbRI) and type II receptor (TbRII). Binding of TGF-b to TbRII activates the intrinsic serine/threonine kinase activity of TbRI, which phosphorylates transcription factors Smad2 and Smad3. Phosphorylated Smad2 and Smad3 combine with Smad4 and translocate into the nucleus, where they function to regulate transcription of specific genes that possess TGF-b response elements in their promoters (5) (6) (7) .
Ultraviolet (UV) irradiation from the sun is a potent environmental hazard capable of damaging cellular DNA and causing mutations (8, 9) . In addition, solar UV irradiation is the primary cause of premature skin ageing (photoageing). We have reported previously that UV irradiation reduces type I procollagen production through impairment of TGF-b signal transduction pathway. This reduction is largely due to repression of TbRII gene expression (10, 11) . We observed that UV irradiation significantly represses TbRII mRNA and protein, but not TbRI, in cultured human skin fibroblasts. In the same study, we also observed that neither TbRII mRNA stability nor TbRII protein stability was altered after UV exposure, indicating that UV repression of TbRII mRNA and protein must result from reduced mRNA transcription or protein synthesis.
We report here that UV irradiation reduces TbRII expression, at least partially, through transcriptional repression. This repression is mediated by a 38-bp sequence in TbRII promoter, in human skin fibroblasts.
Materials and methods

Materials
Dulbecco's modified Eagle's medium, foetal calf serum, trypsin solution, penicillin/streptomycin and L-glutamine were purchased from Gibco (Invitrogen, Carlsbad, CA, USA). [c- 32 p]ATP was obtained from Perkin Elmer (Boston, MA, USA). Type I procollagen, TbRII and NF-Y antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other reagents were purchased from Sigma-Aldrich Company (St. Louis, MO, USA).
Cell culture and UV irradiation
Adult human skin primary dermal fibroblasts were isolated from punch biopsy of healthy adult normal human skin, as described previously (10) . Cells were cultured at 37°C under 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum. Cells were used between passages 5 and 10. UV irradiation of human skin primary dermal fibroblasts was performed as described previously (10) (11) (12) . Briefly, subconfluent cells were irradiated with a UVB/A2 source (50 mJ/cm 2 ) using an Ultralite Panelite lamp containing six FS24T12 UVB-HO bulbs. The UV irradiation intensity was monitored with an IL1400A phototherapy radiometer and a SED240/UVB/W photodetector (International Light, Newbury, MA, USA). A Kodacel filter was used to remove UVC (wavelengths below 290 nm).
Promoter/reporter constructs
A series of TbRII promoter-luciferase 5 0 -deletion constructs (covering 2 kb of TbRII proximal promoter) was kindly provided by Dr. Seong-Jin Kim (National Institute of Health, Bethesda, MD, USA) (13) . Luciferase reporters driven by wild-type and mutant TbRII promoter spanning from À137 to À47 were generated by PCR using mutant templates, which were kindly provided by Dr. James W. Freeman (Department of Medicine, University of Texas Health Service Center, San Antonio, TX, USA) (14) . PCR primers were forward primer 5 0 -CGCTCGAGTGAGGGGCAGCTGAAAGTC-3 0 ;
reverse primer to generate wild-type and mutants (Sp1A, Sp1C and inverted CCAAT) reporters was 5 0 -GCAAGCTTACGTCCAGCCCC TAG-3 0 ; reverse primer for Sp1D mutant was 5 0 -GCAAGCTT-AC GTCGAATTCCTAG-3 0 ; wild-type and mutant TbRII promoterluciferase reporters, spanning from À100 to À62, were generated by PCR using wild-type and mutant templates described above. PCR primers were as follows: forward primer: 5 0 -CGCTCGAGGGC-T GGTCTAGGAAAC-3 0 and reverse primer: 5 0 -GCCTCGAGCAGC-TACGAGAGAGC-3 0 . The PCR products were cloned into pGL-3 luciferase reporter using Hind III and Xho I restriction sites.
Transient transfection of TbRII promoter constructs and luciferase assays
Human skin fibroblasts were transiently transfected and cotransfected with a b-galactosidase, to provide an internal control for transfection efficiency, and the luciferase reporters described above. Transfection was performed by electroporation, according to the manufacturer's protocol (Amaxa Biosystems, Gaithersburg, MD, USA). Aliquots containing identical b-galactosidase activity were used for each luciferase assay. Luciferase activity was measured using an enhanced luciferase assay kit (PharMingen International, San Diego, CA, USA) according to the manufacturer's protocol.
Electrophoretic mobility-shift assay and super shift assay Electrophoretic mobility-shift assays (EMSAs) were performed as described previously (10, 15 
RNA isolation and quantitative real-time RT-PCR
Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Total RNA (100 ng) was reverse-transcribed using Taqman Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA). Real-time PCR was performed on a 7900 Sequence Detector (Applied Biosystems) using Taqman Universal PCR Master Mix Reagents (Applied Biosystems). PCR primers and probes were purchased from Applied Biosystems. Type I procollagen, TbRII and 36B4 primers and probes were described previously (15) . Target gene levels were normalized to the housekeeping gene 36B4, as an internal control for quantification.
Western blot analysis
Western analysis was performed as previously described (10).
Briefly, whole-cell extracts were prepared from cells using wholecell extraction buffer (25 mM HEPES, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% Triton X-100, 0.5 mM DTT, 20 mM b-glycerolphosphate, 0.1 mM Na 3 VO 4 , 2 lg/ml leupeptin and 100 lg/ml PMSF). Protein concentrations were measured by Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA). Proteins were resolved on 6% or 10% SDS-PAGE, transferred to PVDF membrane and reacted with primary antibodies. Protein bands were visualized and quantified with enhanced chemifluorescence (ECF) (Vistra ECF Western Blotting System, GE Healthcare, Piscataway, NJ, USA) following the manufacturer's protocol. The intensities of each band were quantified by STORM MolecularImager (Molecular Dynamics, Sunnyvale, CA, USA) and normalized using b-actin as loading control.
Transfection and siRNA
Human skin fibroblasts were transiently transfected with control siRNA (5 0 -UUCUCCGAACGUGUCACGU-3 0 , Qiagen, Chatsworth,
and designed to target exon 6 of NFY-A (16) (Sigma-Aldrich Company, St Louis, MO, USA), as described previously (17) . All siRNA were transiently transfected into dermal fibroblasts by electroporation (Amaxa Biosystems, Koeln, Germany) as described above. Forty-eight hours after transfection, whole-cell extract and total RNA were prepared. Protein and mRNA levels were determined by Western blot analysis and quantitative real-time RT-PCR, respectively, as described above.
Statistical analysis
Comparisons between groups were determined with the Student's t-test. All P-values are two-tailed and considered significant when P < 0.05.
Results
UV irradiation represses TbRII promoter activity in human skin fibroblasts
Ultraviolet (UV) irradiation significantly reduces type I procollagen gene expression through impairment of TGF-b signal transduction pathway, largely due to repression of TbRII gene expression (11) . This impairment is not due to reduced stability of either TbRII mRNA or protein, indicating that UV repression of expression likely results from reduced synthesis of TbRII mRNA or protein (data not shown). To determine whether UV irradiation alters TbRII mRNA transcription, we transiently transfected a series of TbRII promoter-luciferase 5 0 -deletion constructs (covering 2 kb of the TbRII proximal promoter) into cultured skin fibroblasts. Twenty-four hours after transfection, cells were exposed to UV (50 mJ/cm 2 ). Twenty-four hours after UV irradiation, luciferase activity was determined. These studies identified a 137 base pair region upstream of the transcriptional start site that exhibited high promoter activity and was significantly repressed 60% (n = 8, P < 0.05) by UV irradiation (Fig. 1) . The reporter construct pTbRII-47/+54 also exhibited high promoter activity but was not altered by UV irradiation. These data indicate that the TbRII promoter from À137 to À46 contains transcriptional regulation element(s) that is required for TbRII promoter activity and regulated by UV irradiation.
TbRII promoter activity requires inverted CCAAT box in human skin fibroblasts
Analysis of the TbRII promoter from À137 to À47 revealed three potential SP1-binding sites and one inverted CCAAT transcription regulation site. To determine which of these sites are required for promoter activity and confer regulation by UV irradiation, we generated a series of mutant TbRII promoter luciferase reporter constructs (covering the À137 to À47 base pair region). Mutation of each SP1 site did not alter either promoter activity or repression by UV irradiation (Fig. 2) . In contrast, mutation of the inverted CCAAT box significantly reduced both TbRII promoter activity and responsiveness to UV irradiation (Fig. 2) . These results indicate that the inverted CCAAT box is critical element for TbRII promoter regulation.
To further examine the activity of the inverted CCAAT site, we generated a 38 bp TbRII promoter construct (À100/À62) containing the inverted CCAAT site, but excluding the SP1 sites. After transfection and UV irradiation, we found that this 38 bp region retained full promoter, that is, activity similar to the À137/À47 construct (Fig. 2) , and was repressed by UV irradiation (Fig. 3) . Mutation of the inverted CCAAT site caused loss of promoter activity. Taken together, these data indicate that the inverted CCAAT sequence located between À100 to À62 base pairs is required and sufficient for TbRII proximal promoter activity and confers responsiveness to UV irradiation.
UV irradiation increases protein binding to inverted CCAAT box in the TbRII proximal promoter in human skin fibroblasts
Ultraviolet (UV) irradiation repression of the TbRII promoter may reflect altered protein binding to the inverted CCAAT region of the promoter. To examine this possibility, we performed EMSA using TbRII promoter À100/À62 as probe (Fig. 4a) . UV irradiation substantially increased the amount of the retarded DNA-protein complex (Fig. 4b) . This increased protein binding occurred 2 h post-UV irradiation and remained increased for at least 8 h post-UV exposure. No DNA-protein complex was detected with mutant CCAAT probe (Fig. 4b, right panel) . To confirm the specificity of the retarded complexes formed with the wild-type probe, we performed competition EMSA. DNA-protein complex with the labelled À100/À62 probe was completely abolished by excess unlabelled the wild-type probe, but not by the mutant CCAAT probe (Fig. 4c) . Figure 1 . Ultraviolet (UV) irradiation represses TbRII promoter activity in human skin fibroblasts. Human skin fibroblasts were transiently transfected with TbRII promoter (sequence from À137 to +54 and À47 to +54) luciferase reporter constructs and b-galactosidase expression vector. Cells were exposed to UV irradiation (50 mJ/cm 2 ) 24 h after transfection, and cell lysates were prepared 24 h post-UV irradiation. Luciferase activities were normalized to b-galactosidase activity. Data are means AE SEM for fold change in luciferase activity relative to activity in cells transfected with control vector, pGL-3 luciferase reporter. n = 8. *P < 0.05 versus non-UV-irradiated cells. Figure 2 . TbRII promoter activity requires inverted CCAAT box in human skin fibroblasts. Human skin fibroblasts were transiently transfected with wild-type TbRII promoter (sequence from À137 to À47) luciferase reporter construct, or mutant TbRII promoter luciferase constructs in which Sp1 or inverted CCAAT box was mutated. Cells were cotransfected with the b-galactosidase expression vector. Cells were exposed to ultraviolet (UV) irradiation (50 mJ/cm 2 ) 24 h after transfection, and cell lysates were prepared 24 h post-UV irradiation. Luciferase activities were normalized to b-galactosidase activity. Data are means AE SEM for fold change in luciferase activity relative to activity in cells transfected with wild-type TbRII promoter luciferase construct. n = 6. *P < 0.05 versus non-UV-irradiated cells. Figure 3 . Inverted CCAAT box confers ultraviolet (UV) irradiation repression to TbRII promoter in human skin fibroblasts. Human skin fibroblasts were transiently transfected with the wild-type TbRII promoter (sequence from À100 to À62) luciferase reporter construct, or mutant TbRII promoter luciferase reporter construct in which the inverted CCAAT box was mutated. Cells were co-transfected with the b-galactosidase expression vector. Cells were exposed to UV irradiation (50 mJ/ cm 2 ) 24 h after transfection, and cell lysates were prepared 24 h post-UV irradiation. Luciferase activities were normalized to b-galactosidase activity. Data are means AE SE for fold change in luciferase activity relative to activity of wild-type TbRII promoter luciferase reporter construct. n = 4. *P < 0.05 versus non-UVirradiated cells.
NFY binds to the TbRII promoter activity but binding is not altered by UV in human skin fibroblasts
The CCAAT box is one of the most common cis-elements present in eukaryotic promoters and can serve as a binding site for transcription factor NFY. To determine whether NFY interacts with the inverted CCAAT box in the TbRII promoter, we performed competition EMSA with labelled wild-type TbRII promoter À100/À62 probe and excess unlabelled NFY consensus probe. As shown in Fig. 5a , addition of excess NFY consensus probe reduced protein binding to the TbRII probe. Similar reduction in binding was observed in samples from both non-irradiated and UV-irradiated dermal fibroblasts. In contrast, competition with excess mutant NFY probe did not alter formation of the retarded complexes, indicating that competition with NFY consensus probe was specific. To further confirm NFY binding, we performed super shift assays with antibody that specifically recognizes the NFY-A subunit of NFY. Super-shifted DNA-protein-antibody complexes were detected in samples from both UV-irradiated and non-UV-irradiated dermal fibroblasts (Fig. 5b) . These data indicate that NFY binds to the À100/À62 sequence in the TbRII proximal promoter.
We next investigated whether NFY DNA binding is altered by UV irradiation. To examine this question, we performed EMSA and super shift EMSA with [ 32 P] NFY consensus probe and anti-NFY-A antibody. As shown in Fig. 5c , retarded complexes and super-shifted bands were readily detected in nuclear extracts from non-irradiated skin fibroblasts. Notably, the intensities of both retarded and super-shifted bands were not altered by treatment of fibroblasts with UV irradiation.
Taken together, these data indicate that NFY binds to the 38 bp region of the TbRII promoter, and this binding is not regulated by UV irradiation. Therefore, increased NFY DNA binding is not responsible for increased DNA-protein complex formation with the TbRII promoter, which is observed following UV irradiation.
Discussion
Transcriptional regulation of TbRII gene expression plays a key role in modulating TGF-b responsiveness. Reduced expression of TbRII has been identified in several types of tumor cells. Transfection of wild-type TbRII construct into such tumor cells is able to restore their sensitivity to TGF-b and suppress cell growth (18, 19) . In skin dermis, TGF-b is a major mediator of fibroblast function and extracellular matrix production. Our previous studies have demonstrated that UV irradiation significantly reduces type I procollagen gene expression, in cultured skin fibroblasts, through impairment of TGF-b signalling, largely due to reduction of TbRII (11) . Restoration of TbRII gene expression overcomes the inhibitory effect of UV on type I procollagen production. In addition, knock-down of TbRII by siRNA reduces type I procollagen expression, similar to UV irradiation.
In this report, we have investigated regulation of TbRII transcription by UV irradiation in human dermal fibroblasts. We identified a 38 bp sequence (À100/À62), which harbours an inverted CCAAT box, in the proximal TbRII promoter that is necessary for promoter activity and confers inhibition by UV irradiation. Reduction in TbRII promoter activity by UV irradiation was associated with enhanced protein binding to the 38 bp sequence. NFY binds to the 38 bp promoter region; however, its binding was not altered in response to UV irradiation, implying additional protein(s) are capable of binding to this sequence in response to UV irradiation.
Previous studies have identified several cis-regulatory elements in the TbRII gene promoter (13, 20) . However, the role of these cis-elements in the regulation of TbRII gene transcription appears to be complex and cell-type dependent. We found that human skin fibroblasts, transcription of the TbRII proximal promoter, is dependent on a 38 bp sequence from À100 to À62. This sequence also confers regulation by UV irradiation, which inhibits transcription and induces protein binding.
CCAAT box is one the most common cis-elements present in eukaryotic promoters. Various DNA-binding proteins interact with this element, including NFY. NFY is a heteromeric complex composed of three subunits: NFY-A, NFY-B and NFY-C, all required for CCAAT binding. NFY has been shown to exert both positive and negative gene regulation (21) (22) (23) (24) . We observed that knock-down of NFY-A by siRNA resulted in repression of TbRII promoter activity, indicating NFY function as a positive regulator of TbRII gene expression, in cultured human skin fibroblasts. This conclusion is consistent with reports from Park and others, who studied different cell types (25, 26) .
Nuclear factor Y (NFY) functions via both cooperative and antagonistic interactions with other transcription factors (27) (28) (29) . Cooperative interactions enhance NFY activity, which could act to repress or stimulate promoter activity, depending on promoter context (30) (31) (32) . Conversely, antagonistic interactions act to diminish NFY function (33) (34) (35) . Our data demonstrate that NFY binds to an inverted CCAAT box, which is contained within a 38 bp sequence in the TbRII proximal promoter. This sequence is required for promoter activity, and repression of activity by UV irradiation is associated with increased protein binding to this sequence. Given that NFY is required for promoter activity, a likely scenario is that increased protein(s)-binding in response to UV irradiation antagonizes NFY function, thereby reducing transcription of the TbRII gene (Fig. 6) . The identity of the antagonistic protein(s) remains to be determined.
